ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2015
Comment on: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag".
Nuggehally R SrinivasPubMed ↗Publisher ↗
No numbers read from the abstract.